<TABLE> <S> <C>
<ARTICLE> 6
<SERIES>
<NUMBER> 10
<NAME> FIRST TRUST PHARMACEUTICAL PORTFOLIO
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<INVESTMENTS-AT-COST> 481,941
<INVESTMENTS-AT-VALUE> 548,661
<RECEIVABLES> 9,815
<ASSETS-OTHER> 0
<OTHER-ITEMS-ASSETS> 53,799
<TOTAL-ASSETS> 612,275
<PAYABLE-FOR-SECURITIES> 0
<SENIOR-LONG-TERM-DEBT> 0
<OTHER-ITEMS-LIABILITIES> 38,652
<TOTAL-LIABILITIES> 38,652
<SENIOR-EQUITY> 0
<PAID-IN-CAPITAL-COMMON> 490,963
<SHARES-COMMON-STOCK> 46,024
<SHARES-COMMON-PRIOR> 12,987
<ACCUMULATED-NII-CURRENT> (713)
<OVERDISTRIBUTION-NII> 0
<ACCUMULATED-NET-GAINS> 16,653
<OVERDISTRIBUTION-GAINS> 0
<ACCUM-APPREC-OR-DEPREC> 66,720
<NET-ASSETS> 573,623
<DIVIDEND-INCOME> 2,088
<INTEREST-INCOME> 0
<OTHER-INCOME> 0
<EXPENSES-NET> (2,594)
<NET-INVESTMENT-INCOME> (506)
<REALIZED-GAINS-CURRENT> 16,653
<APPREC-INCREASE-CURRENT> 61,871
<NET-CHANGE-FROM-OPS> 78,018
<EQUALIZATION> 0
<DISTRIBUTIONS-OF-INCOME> 0
<DISTRIBUTIONS-OF-GAINS> 0
<DISTRIBUTIONS-OTHER> 0
<NUMBER-OF-SHARES-SOLD> 47,682
<NUMBER-OF-SHARES-REDEEMED> (14,645)
<SHARES-REINVESTED> 0
<NET-CHANGE-IN-ASSETS> 438,908
<ACCUMULATED-NII-PRIOR> (207)
<ACCUMULATED-GAINS-PRIOR> 0
<OVERDISTRIB-NII-PRIOR> 0
<OVERDIST-NET-GAINS-PRIOR> 0
<GROSS-ADVISORY-FEES> 1,047
<INTEREST-EXPENSE> 0
<GROSS-EXPENSE> 50,009
<AVERAGE-NET-ASSETS> 355,274
<PER-SHARE-NAV-BEGIN> 10.37
<PER-SHARE-NII> (0.02)
<PER-SHARE-GAIN-APPREC> 2.11
<PER-SHARE-DIVIDEND> 0.00
<PER-SHARE-DISTRIBUTIONS> 0.00
<RETURNS-OF-CAPITAL> 0.00
<PER-SHARE-NAV-END> 12.46
<EXPENSE-RATIO> 1.47
</TABLE>